Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.130
-0.020 (-1.74%)
At close: Feb 27, 2026, 4:00 PM EST
1.160
+0.030 (2.65%)
After-hours: Feb 27, 2026, 7:51 PM EST
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $2.03 million as of February 27, 2026. Its market cap has decreased by -67.18% in one year.
Market Cap
2.03M
Enterprise Value
-1.78M
1-Year Change
-67.18%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.16M to $2.03M, a decrease of -92.25%. That is a compound annual growth rate of -43.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 2.03M | -25.29% |
| Dec 31, 2025 | 2.71M | -55.12% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.12% |
| Dec 30, 2022 | 7.82M | -59.15% |
| Dec 27, 2021 | 19.13M | -26.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dermata Therapeutics | 2.91M |
| SciSparc | 2.83M |
| Adial Pharmaceuticals | 2.71M |
| XORTX Therapeutics | 2.49M |
| Lyra Therapeutics | 2.48M |
| Artelo Biosciences | 2.44M |
| Bone Biologics | 2.08M |
| CDT Equity | 2.00M |